Comments on Ren et al.: Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?

Ren HL, Jiang JM, Wang JX, Qu DB, Chen JT (2016) Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis? Eur Spine J. doi:10.1007/s00586-016-4496-2 Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lonnroth K, Weil D, Raviglione M (2010) MDR tuberculosis—critical steps for prevention and control. N Engl J Med 363:1050–1058. doi:10.1056/NEJMra0908076 Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366:2161–2170. doi:10.1056/NEJMoa1108789 Lange C, Abubakar I, Alffenaar J-WC, Bothamley G, Caminero JA, Carvalho ACC, Chang K-C, Codecasa L, Correia A, Crudu V (2014) Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 44:23–63